Novartis & Alcon's takeover

  • 965 views
Uploaded on

Analysis of Novartis & Alcon's takeover in 2009

Analysis of Novartis & Alcon's takeover in 2009

More in: Business
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
965
On Slideshare
0
From Embeds
0
Number of Embeds
1

Actions

Shares
Downloads
25
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Novartis & Alcon
    The takeover
    Jérémie LORRAIN & Kelly BLASCO
  • 2. Introduction
    What is a Takeover?
    Friendly
    Hostile
  • 3. Overview
    Presentation of the companies
    Reasons of the takeover
    Stock Market
    How does Novartis finance it?
  • 4. Novartis
    Swiss pharmaceutical company
    Created in 1996
    2009 turnover: $ 44,3 billion
    Employees: 100 000
  • 5. Alcon
    American pharmaceutical firm
    Founded in 1945 by R.Alexander & W.Coner
    2008 turnover: $ 6 293 billion
    Employees: 15 000
  • 6. Reasons of the takeover
    28 billion dollars
    Strengthen innovation power & diversify its range of medication
    Together they cover more than 70% of the global vision care sector
    Benefice for the shareholders, employees and patients
  • 7. Stock Market - Alcon
    19th February stock price : $ 159.08
    15th March stock price: $162.48
  • 8. Stock Market - Novartis
    • 5thfebruary: Novartis’ shares were worth 57,75 dollars
    • 9. Today: 58,35 dollars
  • How does Novartis finance it?
    $14 billion to be financed
    Strong cash flow
    Mix of bonds and loans
    Selling shares
  • 10. Conclusion
    Future success ?